Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.AuthorsCartron, G.; Bachy, E.; Guidez, S.; Gyan, E.; Gressin, R.; Morineau, N.; Sibon, D.; Casasnovas, O.; Le Gouill, S.; Tilly, H.; Ysebaert, L.; Schiano de Colella, J. M.; Feugier, P.; Virelizier, E. Nicolas; Haioun, C.; Damaj, G.; Tarte, K.; Laurent, C.; Houot, R.; Thieblemont, C.PublicationHematological Oncology, 2021, Vol 39, p1ISSN0278-0232Publication typeArticleDOI10.1002/hon.22_2880